Acme Therapeutics (I) Private Limited, a active private limited company, was established on 14 March 2001 in Panchkula, Haryana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24232HR2001PTC093261. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.80 M and a paid-up capital of ₹1.62 M.
Formerly known as Acme Therapeutics Private Limited, Acme Pharmaceuticals Private Limited. It upholds a compliant status. Employing 302 professional, Its leadership includes Banshidhar Kanhaiyalal (Director), Gopal Krishna (Director), Sanjay Kumar (Director). Past directors included Binod Kumar Agarwal, Rajesh Kumar Jain, Murlidhar Kanhaiyalal. It holds ₹4.25 Cr open charges and ₹1.60 Cr settled loans. Its latest AGM occurred on 27 September 2025, with the balance sheet filed on 31 March 2025. It is based at Flat No 1601, Tower 7A Suncity Parikrama, Sector 20, Panchkula, Haryana, 134109.
U24232HR2001PTC093261
093261
14 March 2001
₹1.80 M
₹1.62 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Acme Therapeutics (I) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Banshidhar Kanhaiyalal | Director | 14 Mar 2001 | Current |
| Gopal Krishna | Director | 01 May 2002 | Current |
| Sanjay Kumar | Director | 21 Oct 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 19 Oct 2019 | Past |
| Pramod Abcsdd | Director | 23 Mar 2009 | Past |
| Pramod Abcsdd | Director | 16 Mar 2009 | Past |
| Pramod Abcsdd | Director | 01 Dec 2008 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Acme Therapeutics (I) Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.01% increase. The company also saw a slight decrease in profitability, with a 0.14% decrease in profit. The company's net worth Soared by an impressive increase of 13.16%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Acme Therapeutics (I) had a promoter holding of 95.69% and a public holding of 4.31%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹42,500,000.00
₹16,025,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jan 2025 | Hdfc Bank Limited | ₹2.75 Cr | Open |
| 13 Feb 2024 | Others | ₹1.50 Cr | Open |
| 20 Mar 2020 | Others | ₹8.33 M | Satisfied |
| 10 Dec 2015 | Kotak Mahindra Bank Limited | ₹4.20 M | Satisfied |
| 03 Jun 2004 | Punjab National Bank | ₹3.50 M | Satisfied |
Explore comprehensive loan charge details -
Acme Therapeutics (I) has a workforce of 302 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Acme Therapeutics (I), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Acme Therapeutics (I)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 20 Mar 2020 via Charge ID 100341247 with Others was fully satisfied on 19 Nov 2025. was documented.
Progress on Acme Therapeutics (I) Private Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records. was documented.
Progress on Acme Therapeutics (I) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.
The activity A charge with Hdfc Bank Limited amounted to Rs. 27.50 M with Charge ID 101049295 was registered on 27 Jan 2025. was completed.
The activity A charge with Others amounted to Rs. 15.00 M with Charge ID 100875794 was registered on 13 Feb 2024. was completed.
A charge with Others amounted to Rs. 8.33 M with Charge ID 100341247 was registered on 20 Mar 2020. was recorded as a recent event.
The CIN of Acme Therapeutics (I) Private Limited is U24232HR2001PTC093261.
Acme Therapeutics (I) Private Limited is headquartered at Flat No 1601, Tower 7A Suncity Parikrama, Sector 20, Panchkula, Haryana, 134109.
Acme Therapeutics (I) Private Limited was incorporated on 14 March 2001.
The current directors of Acme Therapeutics (I) Private Limited are
The primary industry of Acme Therapeutics (I) Private Limited is Trade.
Acme Therapeutics (I) Private Limited is unlisted.
The authorized capital of Acme Therapeutics (I) Private Limited is ₹1.80 M, and the paid-up capital is ₹1.62 M.
The compliance status of Acme Therapeutics (I) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
_PRIVATE_LIMITED.webp)
Company Details
+91-XXXXXXXXXX